Genomic Cancer Testing Market Growth Accelerated by Innovation in Cancer Testing Techniques

Genomic Cancer Testing Market


Genomic cancer testing helps in determining cancer type and its driver genes for effective treatment of cancer. Such testing provide accurate diagnosis and assist oncologists in personalized treatment planning. The genomic profiling helps analyze cancer cells at molecular level and recommend targeted therapy. Advancements in next-generation sequencing technologies have enabled high-throughput and cost-effective cancer testing.

The global Genomic Cancer Testing Market is estimated to be valued at US$ 13.67 billion in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The innovation in cancer testing techniques has accelerated the growth of Genomic Cancer Testing Market. Next generation sequencing techniques such as whole genome sequencing and whole exome sequencing help analyze multiple genes simultaneously and provide comprehensive genomic profile of cancer. This enable accurate diagnosis and selection of personalized treatment for patients. Such advance testing techniques analyze both germline and somatic genetic changes and have emerged as standard of care for cancer treatment management. This trend is expected to continue during forecast period with further advancement in sequencing technologies.

Segment Analysis
Genomic cancer testing market is segmented based on technology, application and end user. The sequencing technology segment dominated the market in 2022 due to reducing cost of sequencing and increasing use of sequencing for diagnosis and treatment of cancer. Sequencing allows detection of genetic mutations and is used to tailor treatment based on genomic profile of cancer.

Key Takeaways
Global Genomic Cancer Testing Market Size is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America dominated the genomic cancer testing market in 2022 owing to presence of major pharmaceutical companies, high healthcare expenditure and favourable reimbursement policies. However, Asia Pacific is expected to register highest growth rate over the forecast period due to growing healthcare spending, increasing awareness regarding precision medicine and expanding pharmaceutical industry in the region.

Key players: Key players operating in the genomic cancer testing market are Myriad Genetics, Foundation Medicine, Color Genomics, Illumina, Genomic Health, Adaptive Biotechnologies, Natera, Roche, Guardant Health and Biodesix. These players are focusing on developing innovative targeted therapy and precision diagnostic tests to customize cancer treatment.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more